Navigation Links
Lexicon to Present at BIO International Convention
Date:4/28/2010

ch team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct preclinical and clinical development of its potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in L
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
2. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
3. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
4. Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
5. Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
6. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
7. Lexicons Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
8. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
9. Lexicon Announces Pricing of Common Stock in Public Offering
10. Lexicon Announces Completion of Public Offering of Common Stock
11. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 InfuSystem Holdings, Inc. ... and related services for the healthcare industry in ... , announced today it has secured a new $45.0 million ... its previous $36.5 million credit facility with its prior lender ... entered into the new five-year senior secured credit agreement comprised ...
(Date:3/26/2015)... , 26. März 2015  Die National ... vom 1. April 2015 an Zulassungsanträge für Domainnamen ... Apotheken annehmen. Seit dem Start des .Pharmacy ... über 275 .pharmacy-Domainnamen zugelassen, die für die ... beantragt wurden. Die NABP startete .pharmacy TLD, ...
(Date:3/26/2015)... Editor Note: For more information about ... Investor-Edge has initiated coverage on the following equities: Mylan ... SLXP ), Hospira Inc. (NYSE: HSP ), ... (NASDAQ: AKRX ). Free research report on Mylan ... markets declined on Wednesday, March 25, 2015, as the ...
Breaking Medicine Technology:InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 4Alle abgebenden Apotheken berechtigt, um ab dem 1. April 2015 .Pharmacy-Domainnamen zu beantragen 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 3Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 4Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 5
... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... company completed its previously announced acquisition of AB Sanitas ... Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ... and markets a broad range of pharmaceutical products primarily ...
... Medical Inc. (NYSE: SMA ), a leading ... implants, surgical instruments, and sterilization cases and trays, announced ... of Olsen Medical. Olsen Medical is a ... of electrosurgical instruments and accessories. It manufactures a full ...
Cached Medicine Technology:Symmetry Medical Closes Olsen Medical Acquisition 2
(Date:3/26/2015)... 26, 2015 Pacific Medical LLC, the ... to be featured on Innovations with Ed Begley Jr, ... 2015. The episode will repeat on local cable ... the Pacific Medical home page at: http://www.pacificmedicalsupply.com . ... it is reassuring to trust the integrity of the ...
(Date:3/26/2015)... On March 5, 2015, Portland Trail ... for the season with a torn Achilles tendon in ... Blazers were competing against Dallas, and was confirmed via ... Silva, M.D., who has treated many professional athletes, voiced ... could be prevented. , "Part of the problem ...
(Date:3/26/2015)... 26, 2015 In the key developed markets, ... 2013 and is set to decrease through 2020 at a ... growth is expected up to 2017 at a 2.6% CAGR ... be owing to the surging penetration of fixed-dose combination drugs ... Plus, Valturna, Benicar HCT, and Tekamlo), a hike in the ...
(Date:3/26/2015)... In preparation for the 2016 United States Presidential ... Becic, has issued “report cards” for potential candidates ... as well as their promotion of health and fitness ... Cruz, who has officially announced his candidacy for the ... have shown interest in running for office. This report ...
(Date:3/26/2015)... With the rapidly growing healthcare market ... their care, its not just doctors who are now ... background want a piece of the action. HealthSource Chiropractic ... increase in franchises purchased by people with no health ... Chiropractic? , Chiropractic is an exploding $12.7 billion dollar ...
Breaking Medicine News(10 mins):Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 2Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 4Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 2Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 3Health News:HealthSource Chiropractic Franchise Expands National Footprint as Investors Buy In 2Health News:HealthSource Chiropractic Franchise Expands National Footprint as Investors Buy In 3
... Patients with normal left ventricular function who undergo ... coronary intervention (PCI) with drug-eluting stents (DES) had ... the multicenter, retrospective study are reported in the ... a journal published by Wiley-Blackwell on behalf ...
... In the war between drugs and drug-resistant diseases, is ... diseases a big competitive advantage?, asks a research paper ... the National Academy of Sciences. The paper argues ... managing the evolution and slowing the spread of drug-resistant ...
... , WEDNESDAY, June 22 (HealthDay News) -- A poor "gut sense" ... a new study suggests. Researchers had 71 ninth graders enrolled ... their innate sense of numbers, such as asking them to guess ... actually count them. Researchers also divided the students into four ...
... Hepatocellular carcinoma is the most common cancer to strike ... sub-Saharan Africa and Southeast Asia, are diagnosed with it ... A big obstacle to treatment of liver cancer ... ultrasound, CT and MRI scans, spot tumors only when ...
... for patients in a medical intensive care unit in a ... tracking thousands of important details, some of which could get ... copilot to make sure nothing slips by. A new ... care unit could use a copilot, too. The mortality rate ...
... water. What happens? As soon as the soap hits the water, ... Now, what if the sink was a cancer cell, the globs ... potential drug? According to new research from the University of Toronto ... membrane (a.k.a., the edge of the sink)and make the cancer cell ...
Cached Medicine News:Health News:Positive results for unprotected left main coronary artery PCI with drug-eluting stents 2Health News:Slowing the spread of drug-resistant diseases is goal of new research area 2Health News:Slowing the spread of drug-resistant diseases is goal of new research area 3Health News:Slowing the spread of drug-resistant diseases is goal of new research area 4Health News:Math Learning Disabilities Linked to Poor 'Gut Sense' of Numbers 2Health News:Gold nanoparticles help earlier diagnosis of liver cancer 2Health News:Nudging doctors in intensive care unit reduces deaths 2Health News:Nudging doctors in intensive care unit reduces deaths 3Health News:Molecular glue sticks it to cancer 2
Aaron Burr II with disposable 1mm burr for corneal rust ring removal and a diamond burr tip for polishing the pterygium bed after surgical removal and for lid margin lesions....
Algerbrush II corneal rust ring remover battery powered...
Non-Illuminated Trial Lens Set with lenses mounted in plastic frames....
Plus cylinders only trial lens set....
Medicine Products: